Press release
Cancer Immunotherapy Market size to Reach USD 311.43 Billion by 2031 Driven by Combination Therapies and Manufacturing Scale-Up
Cancer Immunotherapy Market Size & Trends | 2031
Cancer Immunotherapy Market Overview
According to Mordor Intelligence, the cancer immunotherapy market size was valued at USD 144.80 billion in 2025 and is expected to grow to USD 311.43 billion by 2031, reflecting consistent cancer immunotherapy market growth during the forecast period. This upward trend highlights how immunotherapy has moved from a niche treatment option to a widely adopted approach in cancer care.
The cancer immunotherapy industry is benefiting from increasing acceptance among clinicians and patients, especially as long-term survival outcomes improve across several cancer types. Regulatory approvals for advanced therapies, including cell-based treatments and targeted immune therapies, have strengthened confidence in this treatment class.
Report Overview: https://www.mordorintelligence.com/industry-reports/cancer-immunotherapy-market?utm_source=openpr
Key Cancer Immunotherapy Market Trends
Rising Adoption of Combination Therapies
One of the most important cancer immunotherapy market trends is the growing use of combination therapies. Companies are focusing on combining immune checkpoint inhibitors with other treatment modalities such as anti-angiogenic agents and chemotherapy. This approach is improving treatment outcomes, particularly in cases where single therapies show limited response.
Expansion of Cell-Based and Personalized Therapies
The cancer immunotherapy industry is seeing strong interest in personalized medicine, especially with cell-based therapies such as CAR-T and tumour-infiltrating lymphocyte treatments. These therapies are tailored to individual patients, improving effectiveness and contributing to sustained cancer immunotherapy market growth.
Manufacturing Improvements and Cost Optimization
Another key cancer immunotherapy market trend is the focus on reducing production costs. Companies are investing in automated systems, closed manufacturing setups, and localized production units. These changes are helping improve scalability and affordability, which in turn supports broader cancer immunotherapy market share expansion.
Check out more details and stay updated with the latest industry trends, including the Japanese version for localized insights: https://www.mordorintelligence.com/ja/industry-reports/cancer-immunotherapy-market?utm_source=openpr
Cancer Immunotherapy Market Segmentation
By Therapy Type
Monoclonal antibodies
Cancer vaccines
Immunomodulators
Cell-based therapies
Oncolytic virus therapies
Combination regimens
By Cancer Type
Lung cancer
Breast cancer
Melanoma and skin cancers
Prostate cancer
Hematologic malignancies
Other cancer types
By End User
Hospitals and clinics
Academic and research centers
Ambulatory and specialty centers
By Route of Administration
Intravenous
Subcutaneous and intratumoral
By Geography
North America
Europe
Asia-Pacific
Middle East and Africa
South America
Explore Our Full Library of Healthcare Research Report:
https://www.mordorintelligence.com/market-analysis/healthcare?utm_source=openpr
Cancer Immunotherapy Market Key Players and Competitive Landscape
The cancer immunotherapy market is moderately fragmented, with a mix of established pharmaceutical companies and emerging biotechnology firms competing for cancer immunotherapy market share. Leading players continue to focus on expanding their product portfolios, investing in research, and forming strategic partnerships.
Key Players in the Cancer Immunotherapy Industry
Bristol-Myers Squibb
Merck & Co., Inc.
F. Hoffmann-La Roche Ltd
AstraZeneca PLC
Pfizer Inc.
Explore more insights on cancer immunotherapy competitive landscape: https://www.mordorintelligence.com/industry-reports/cancer-immunotherapy-market/companies?utm_source=openpr
Conclusion
The cancer immunotherapy market is set to remain one of the most important segments within the global oncology landscape. With increasing clinical success rates and expanding treatment applications, the cancer immunotherapy market size is expected to grow steadily over the coming years.
The combination of strong research pipelines, supportive regulatory environments, and ongoing investments in manufacturing will continue to drive cancer immunotherapy market growth. In addition, the shift toward personalized medicine and combination therapies will play a key role in shaping future cancer immunotherapy market trends.
Get detailed insights on the cancer immunotherapy market:
https://www.mordorintelligence.com/industry-reports/cancer-immunotherapy-market?utm_source=openpr
Industry Related Reports
Cancer Cachexia Market:
The market is growing due to increasing cancer prevalence, rising awareness of cachexia management, and advancements in targeted therapies and supportive care treatments.
Get more insights: https://www.mordorintelligence.com/industry-reports/cancer-cachexia-market?utm_source=openpr
Acute Myeloid Leukemia Therapeutics Market size:
The market is projected to grow from USD 3.18 billion in 2026 to USD 5.18 billion by 2031 at a CAGR of 10.29%, driven by rising incidence of leukemia and advancements in targeted and personalized therapies.
Get more insights: https://www.mordorintelligence.com/industry-reports/acute-myeloid-leukemia-therapeutics-market?utm_source=openpr
T-Cell Lymphoma Market share:
The market is expected to grow from USD 2.36 billion in 2025 to USD 3.25 billion by 2030 at a CAGR of 6.66%, fueled by increasing research activities and development of novel immunotherapies.
Get more insights: https://www.mordorintelligence.com/industry-reports/t-cell-lymphoma-market?utm_source=openpr
About Mordor Intelligence:
Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.
With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.
Mordor Intelligence, 11th Floor, Rajapushpa Summit, Nanakramguda Rd, Financial District, Gachibowli, Hyderabad, Telangana - 500032, India.
For any inquiries or to access the full report, please contact:
media@mordorintelligence.com
https://www.mordorintelligence.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cancer Immunotherapy Market size to Reach USD 311.43 Billion by 2031 Driven by Combination Therapies and Manufacturing Scale-Up here
News-ID: 4447650 • Views: …
More Releases from Mordor Intelligence Private Limited
Urgent Care Apps Market Size to Reach USD 28.84 Billion by 2031 as Growing Deman …
Urgent Care Apps Market Overview
According to Mordor Intelligence, the urgent care apps market size is expected to grow from USD 5.90 billion in 2026 to USD 28.84 billion by 2031, registering a CAGR of 37.32% during the forecast period. The urgent care apps industry is benefiting from growing healthcare digitization, broader virtual care acceptance, and increasing patient preference for mobile-first healthcare access.
Healthcare systems are investing heavily in…
Neurodiagnostics Market Size to Reach USD 13.81 Billion by 2031 with Rising Focu …
Neurodiagnostics Market Overview
According to Mordor Intelligence, the neurodiagnostics market size is estimated at USD 9.79 billion in 2026 and is projected to reach USD 13.81 billion by 2031, registering a CAGR of 7.12% during the forecast period. The neurodiagnostics industry is benefiting from growing adoption of artificial intelligence-assisted diagnostics, increasing use of blood-based biomarkers, and wider deployment of minimally invasive testing systems across hospitals and specialized neurology centers.
Healthcare…
Intrathecal Pumps Market Size to Reach USD 542.43 Million by 2031 with Rising Pr …
Intrathecal Pumps Market Overview
According to Mordor Intelligence, the intrathecal pumps market size is estimated at USD 403.96 million in 2026 and is projected to reach USD 542.43 million by 2031, registering a CAGR of 6.07% during the forecast period. The intrathecal pumps industry is benefiting from growing demand for therapies that reduce systemic opioid exposure while improving dosing precision and long-term patient management.
Hospitals and pain management centers are…
Contrast Media Injectors Market Forecast to Reach USD 3.03 Billion by 2031 as Au …
Contrast Media Injectors Market Overview
According to Mordor Intelligence, the contrast media injectors market size is expected to grow from USD 2.11 billion in 2026 to USD 3.03 billion by 2031, registering a CAGR of 7.54% during the forecast period. The market is seeing steady demand from hospitals, diagnostic imaging centers, and interventional care facilities that require accurate and controlled contrast delivery during imaging procedures.
The growing use of automated…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For…
